CSIMarket
 
Opko Health Inc   (OPK)
Other Ticker:  
 
 
Price: $0.9965 $0.05 5.338%
Day's High: $1.01 Week Perf: -3.25 %
Day's Low: $ 0.96 30 Day Perf: 0.94 %
Volume (M): 7,285 52 Wk High: $ 2.24
Volume (M$): $ 7,260 52 Wk Avg: $1.49
Open: $0.96 52 Wk Low: $0.85



 Market Capitalization (Millions $) 749
 Shares Outstanding (Millions) 752
 Employees 4,500
 Revenues (TTM) (Millions $) 867
 Net Income (TTM) (Millions $) -208
 Cash Flow (TTM) (Millions $) -42
 Capital Exp. (TTM) (Millions $) 20

Opko Health Inc
Opko Health Inc is a multi-billion dollar healthcare provider that specializes in diagnostic and pharmaceutical products, especially those related to genetic testing, diagnostics and medical devices along with pharmaceuticals. Founded by Dr. Phillip Frost in 1991, the company is headquartered in Miami, Florida and has a global presence across North America, Europe, Asia and South America. The company has a diverse portfolio of products and services with emphasis on precision medicine and personalized healthcare.

Opko Health has three main divisions e pharmaceuticals, diagnostics and laboratory services. They provide genomic testing and analysis to detect and treat various diseases such as cancer, hepatitis, cardiovascular diseases, endocrinology and infectious diseases. The company's diagnostics division produces a wide range of products, including genetic and infectious disease tests and imaging services. They have also developed a Point-of-Care (POC) testing device for COVID-19, which can be used at clinics, hospitals and testing centers.

The company's pharmaceutical division develops and commercializes products for various diseases such as chronic kidney disease, growth hormone deficiency, vitamin D deficiency and prostate cancer. OPKO Biologics is the subsidiary of the company which produces a range of products based on innovative technology such as RNA interference (RNAi) and gene therapy.

Opko Health also provides laboratory services to medical providers, hospitals and clinics across the world with their subsidiary BioReference Laboratories. The laboratory services include molecular diagnostics, genomic testing and pathology services. It has been recognized for quality and performance with clinical excellence awards from various medical organizations.

Opko Health has a strong pipeline of products with a focus on precision medicine and personalized healthcare. It has both in-house R&D and collaborations with other pharmaceutical companies to develop new treatment and diagnostic products that meet patient needs. The company has also received several approvals from the US Food and Drug Administration (FDA) for its products and devices.

In conclusion, Opko Health Inc is a major healthcare provider with an extensive range of products and services, and a strong focus on innovation, precision medicine and personalized healthcare. It has a global presence and is dedicated to improving patient outcomes and creating value for shareholders.


   Company Address: 4400 Biscayne Blvd. Miami 33137 FL
   Company Phone Number: 575-4100   Stock Exchange / Ticker: NASDAQ OPK
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Financing Agreement

OPKO Health Shows Strategic Finesse with $200 Million Offering as Repurchase Program Steers Shareholder Value and Financial Strength

Published Fri, Jan 5 2024 4:31 AM UTC

OPKO Health Announces Strategic Allocation of Proceeds from Private Offering and Launches Ambitious Stock and Note Repurchase Program
OPKO Health, a leading healthcare company, has recently declared the pricing of its private offering of $200 million Convertible Senior Notes due in 2029. The issuance is set to generate substantial proceeds, which the company plans to all...

Financing Agreement

OPKO Health Empowers Financial Reinforcement with Private Offering of Convertible Senior Notes: Unveiling a Blueprint for Success

Published Wed, Jan 3 2024 10:06 PM UTC

Proceeds to Be Utilized for Repurchasing Common Stock and the Convertible Senior Notes: OPKO Health's Latest Move in Ensuring Financial Stability
OPKO Health, a leading healthcare company committed to developing innovative solutions, recently made a significant announcement regarding its fundraising strategy. The company has put forth plans to conduct a private offering ...

Opko Health Inc

Opko Health Inc Reports Minimal Year-on-Year Revenue Decline in Q3 2023

Opko Health Inc, despite recent financial challenges, is gearing up for a potentially promising future in the stock market. The company may have reported a loss in its most recent fiscal period, but there are reasons to be optimistic.
While Opko Health Inc did experience a slight increase in losses per share compared to the same period last year and the preceding quarter, it's important to remember that financial performance can vary from quarter to quarter. It is crucial to analyze the broader trends and factors at play.

Opko Health Inc

Opko Health Inc Triumphantly Battles Fiscal Challenges, Showcasing Remarkable Improvement in Q2 2023 Financial Report

Opko Health Inc, a major player in the pharmaceutical preparation industry, recently released its financial report for the interval closing June 30, 2023. The report shows a mixed performance for the company, with some positive and negative changes in key financial indicators.
One positive aspect highlighted in the report is that Opko Health Inc managed to reduce its losses per share compared to the previous year. In June 2023, the company reported a loss of $0.03 per share, significantly better than the $0.14 loss per share in the same period last year. Additionally, the company's deficit improved from $0.02 per share in the previous reporting period.

Opko Health Inc

Opko Health Inc. Surges Ahead: Dramatic Turnaround Signaled by Impressive Financial Performance in Q1 2023

Opko Health Inc. has shown strong signs of improvement in their financial performance in the first quarter of 2023. The healthcare company reported a notable decrease in loss per share from $-0.08 to $-0.02 per share, indicating a significant positive shift in their financial position.
Not only did Opko Health Inc. improve their loss per share, but their income per share also showed improvement. It moved from $-0.10 per share in the previous quarter to an undisclosed amount. This highlights that the company has successfully taken measures to control their expenses and boost their income.






 

Opko Health Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com